Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REBIF for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 207 adverse event reports in the FDA FAERS database where REBIF was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for REBIF

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 158 9.0% 3 99
Injection site erythema 137 7.8% 1 26
Influenza like illness 128 7.3% 2 23
Fatigue 123 7.0% 1 45
Injection site pain 105 6.0% 1 22
Headache 96 5.5% 2 26
Injection site bruising 74 4.2% 0 16
Pyrexia 74 4.2% 5 33
Fall 73 4.2% 2 36
Pneumonia 69 4.0% 12 42
Urinary tract infection 69 4.0% 8 46
Depression 65 3.7% 3 22
Pain 63 3.6% 0 23
Hypertension 61 3.5% 1 28
Malaise 61 3.5% 2 30

Other Indications for REBIF

Multiple sclerosis (989) Product used for unknown indication (516) Secondary progressive multiple sclerosis (16)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

REBIF Full Profile All Relapsing-remitting multiple sclerosis Drugs REBIF Demographics REBIF Timeline